Nationwide Children's News Releases
Viewing: 61-70 of 99 | All
May 07, 2013
Family Foundations Fund Critical Study Necessary For Clinical Trials And Enter Into Agreement With Nationwide Childrens Hospital To Ensure Data Access For Lysosomal Storage Disease MPS III
Nearly 50 years to the day since Dr. Sylvester Sanfilippo first characterized the disease Mucopolysaccharidosis (MPS) III in a presentation to the American Pediatric Society, three parent-run foundations have awarded investigators at Nationwide Children’s Hospital in Columbus, OH with a
Apr 18, 2013
Dr. Brian Kaspar First Recipient of Grant Morrow, III, MD, Endowed Chair in Pediatric Research at Nationwide Childrens Hospital
During a recent ceremony, Brian Kaspar, PhD, was named the first recipient of the Grant Morrow, III, MD, Endowed Chair in Pediatric Research at Nationwide Children’s Hospital. This endowed chair is supported by Arthur E. Shepard and Dorothy D.
Mar 13, 2013
Families of SMA and Nationwide Childrens Hospital Announce Multi-Million Dollar Award from NINDS to Advance CNS-Directed Gene Therapy for Spinal Muscular Atrophy
Nationwide Children’s Hospital and Families of Spinal Muscular Atrophy (Elk Grove Village, IL) announce the award of a multi-million dollar cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS) to advance a gene therapy development program for Spinal
Feb 18, 2013
2013 Technology Showcase Presented by The Research Institute at Nationwide Children's Hospital
The Office of Technology Commercialization in The Research Institute at Nationwide Children’s Hospital will present the “2013 Technology Showcase” Thursday, March 14, 2013 from 1 to 4 p.m.
Jan 31, 2013
Sophias Cure Foundation Donates $650,000 in 2012 to Nationwide Childrens Hospital
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital, along with a team of Spinal Muscular Atrophy (SMA) researchers and clinicians, received $650,000 in grants in 2012 from Sophia’s Cure Foundation for SMA
Dec 07, 2012
Dr. John Barnard First Recipient of Ann I. Wolfe Endowed Chair in Research Leadership at Nationwide Children's Hospital
During the December 6 meeting of the Joint Boards of Directors at Nationwide Children’s Hospital, John Barnard, MD, President of The Research Institute at Nationwide Children’s was announced as the first recipient of the Ann I. Wolfe Endowed Chair in Research Leadership.
Oct 25, 2012
Mouse Model Could Help Identify Viral Vectors that May Cause Tumors
Investigators at Nationwide Children’s Hospital have identified a mouse model that could help evaluate the risk that viral vectors used in gene therapy might promote tumor formation as a side-effect. The study appears in Molecular Therapy.
Oct 05, 2012
Exon-Skipping Shows Promise in Duchenne Muscular Dystrophy
Results from a Phase IIb extension trial of the drug eteplirsen show an increased ability to walk in boys with Duchenne muscular dystrophy Eteplirsen, a drug that skips exon 51 of the dystrophin gene, may improve quality of life for patients with Duchenne muscular dystrophy and slow disease
Jul 23, 2012
RNA Interference May Provide the First Therapy for Facioscapulohumeral Muscular Dystrophy
Scientists may one day be able to treat the third most common muscular dystrophy, facioscapulohumeral muscular dystrophy (FSHD), by taking advantage of a system within living cells that helps control gene activation.
Jul 09, 2012
New Gene Transfer Strategy Shows Promise for Limb Girdle and Other Muscular Dystrophies
The challenge of treating patients with genetic disorders in which a single mutated gene is simply too large to be replaced using traditional gene therapy techniques may soon be a thing of the past.